Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation book cover
Book

Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation

Andrew W. Lo headshotAndrew W. LoCharles E. and Susan T. Harris Professor, MIT Sloan
Published2022
PublisherPrinceton University Press
About the book

Modern Financial Analysis for Accelerating Biomedical Innovation

An introductory finance textbook for the healthcare industry

We are living in a golden age of biomedical innovation, yet entrepreneurs still struggle with the so-called Valley of Death when seeking funding for their biotech start-ups. In Healthcare Finance, Andrew Lo and Shomesh Chaudhuri show that there are better ways to finance breakthrough therapies, and they provide the essential financial tools and concepts for creating the next generation of healthcare technologies.

Geared for MBA and life sciences students, as well as biopharma executives and healthcare investment professionals, this textbook covers the theory and application of financial techniques such as diversification, discounted cash flow analysis, real options, Monte Carlo simulation, and securitization, all within the context of managing biomedical assets. The book demonstrates that more efficient funding structures can reduce financial risks, lower the cost of capital, and bring more lifesaving therapies to patients faster. Readers will gain the background, framework, and techniques needed to reshape the healthcare industry in positive ways. Finance doesn’t have to be a zero-sum game, and Healthcare Finance proves that it is possible to do well by doing good.

  • Explores new financing methods for the biopharma industry
  • Provides accessible explanations for making good business decisions in the life sciences
  • Analyzes real-world examples, case studies, and practical applications
  • Includes access to videos of lectures and recitations, interactive figures, self-graded problem sets, and other online content
Meet Andrew

About Andrew W. Lo

Is it irrational to assume that markets behave rationally? That question led Andrew W. Lo to rethink the efficient markets hypothesis, a cornerstone of modern financial theory, and down an unexpected path through behavioral finance, psychology, cognitive neuroscience, artificial intelligence and, ultimately, evolutionary biology. The result is the Adaptive Markets Hypothesis, set out in his acclaimed book Adaptive Markets, which explains how markets and financial institutions adapt to changing environments just as living species do. The hypothesis, he explains, "is meant to reconcile these two schools of thought in a framework that allows both to reflect their incredibly important contributions to what we experience in the real world."

Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering and a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory. Named one of the world's 100 most influential people by TIME, he is also a serial entrepreneur: founder of AlphaSimplex, an asset management company, and co-founder of QLS Advisors, Quantile Health, Uncommon Cures and BridgeBio Pharma, a biotechnology company developing therapies for genetic diseases. Inspired by his own family's struggles with access to cancer treatments, he works to bridge the gap between science and finance, helping health care institutions, drug companies and biotech founders improve patient outcomes along with their bottom lines.

Inquiries

Bring this book to your organization

Tell us about your event and we will be in touch right away.

Step 1 submitted, your details are with us.

A few more optional questions help us come back with something specific. Skip any of them.

Format

Thank you, your inquiry is on its way.

A Stellant advisor will be in touch shortly about Andrew W. Lo.

Related topics

Explore the ideas behind the book